eli lilly glp-1 drug FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - GLP-1 ad war leads to

There is: No evidence that Epitalon can shrink existing tumors in humans No human clinical trials testing its use in oncology No mechanistic studies confirming how Epitalon affects tumor microenvironments or immune evasion in vivo What we do have is a compelling preventive profile in animal models, especially where aging and genetic susceptibility intersect

Reported half-life Not applicable here - GHK-Cu isn't characterised as a dosed medicine, so there's no clinical half-life to quote

G.AschmannH

There are many types of synthetic peptides , such as BPC-157 (for gut and joint healing), TB-500 (for muscle and tissue repair), and CJC-1295 (for growth hormone release)

& DiAntonio, A